secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immunome Inc. (IMNM)
CIK:        0001472012
Form:       8-K
Filed at:   2025-12-17T23:59:59+00:00
Accession:  0001193125-25-322877
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Immunome prices $400M public offering of 18.6M shares at $21.50 per share
-------------------------------------------------------------------------

- Public offering of 18,625,000 shares at $21.50/share; gross proceeds ~$400M.
- Underwriters granted 30-day option for up to 2,793,750 additional shares at same price.
- Offering expected to close December 18, 2025; joint bookrunners include Leerink, J.P. Morgan, TD Cowen, Goldman Sachs, Guggenheim.
- All shares sold by Immunome; proceeds before underwriting discounts and expenses.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1472012/000119312525322877/0001193125-25-322877-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1472012/000119312525322877/d27244d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-322877

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer